Weixian Min
Impact in
- Developmental Neuroscience top 10%
- Neurogenesis and neuroplasticity mechanisms
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Biochemical and Molecular Research 4
- Genetics 6
- Genetics and Neurodevelopmental Disorders 2
- Virus-based gene therapy research 2
- Co-authors
- Tony F. Cruz (3 shared papers)Joan M. Boggs (3 shared papers)Eyal Grunebaum (9 shared papers)Chaim M. Roifman (3 shared papers)Dina N. Arvanitis (2 shared papers)Helen M. Burt (2 shared papers)John K. Jackson (2 shared papers)Huimin Wang (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (1 paper)Molecular and Cellular Biochemistry (1 paper)Neurobiology of Disease (1 paper)Journal of Neurochemistry (1 paper)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Weixian Min
17 papers receiving 577 citations
Peers
Comparison fields: 5 of 87
- Developmental Neuroscience 44
- Pharmaceutical Science 43
- Immunology and Allergy 31
- Cell Biology 76
- Immunology 92
Countries citing papers authored by Weixian Min
This map shows the geographic impact of Weixian Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixian Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixian Min more than expected).
Fields of papers citing papers by Weixian Min
This network shows the impact of papers produced by Weixian Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixian Min. The network helps show where Weixian Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Weixian Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 87 | |
| 2 | 1995 | 71 | |
| 3 | 2004 | 71 | |
| 4 | 2004 | 70 | |
| 5 | 2005 | 63 | |
| 6 | 1995 | 57 | |
| 7 | 1996 | 44 | |
| 8 | 2004 | 38 | |
| 9 | 2012 | 20 | |
| 10 | 1997 | 13 | |
| 11 | 2018 | 13 | |
| 12 | 2008 | 11 | |
| 13 | 2019 | 11 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2018 | 3 | |
| 17 | 2010 | 1 |
About Weixian Min
Weixian Min is a scholar working on Molecular Biology, Genetics, Epidemiology, Cell Biology and Immunology, having authored 17 papers that have together received 589 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (4 papers), Cytomegalovirus and herpesvirus research (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Adenosine and Purinergic Signaling (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Cell Adhesion Molecules Research (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Developmental Neuroscience (44 citations), Pharmaceutical Science (43 citations), Immunology and Allergy (31 citations), Cell Biology (76 citations) and Immunology (92 citations). Weixian Min has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Tony F. Cruz, Joan M. Boggs, Eyal Grunebaum, Chaim M. Roifman, Dina N. Arvanitis, Helen M. Burt, John K. Jackson, Huimin Wang, Pamela D. Arora and Christopher A. McCulloch. Their work appears in journals such as Frontiers in Immunology, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Molecular and Cellular Biochemistry, Neurobiology of Disease and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.